Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohort

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e148-50. doi: 10.1097/QAI.0000000000000087.

Authors

Maria Patrizia Carrieri¹, Camelia Protopopescu, François Raffi, Laura March, Philippe Reboud, Bruno Spire, Catherine Leport; ANRS CO8 APROCO-COPILOTE Study Group

Affiliation

¹ *INSERM, UMR912 (SESSTIM), Marseille, France †Aix Marseille Université, UMR_S912, IRD, Marseille, France ‡ORS PACA, Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France §CHU Hôtel-Dieu, Nantes, France ‖INSERM, U897, Université Bordeaux Segalen, ISPED, Bordeaux, France ¶Université Paris Diderot, Sorbonne Paris Cité, UMR 738, Paris, France #INSERM, UMR 738, Paris, France.

PMID: 24346641
DOI: 10.1097/QAI.0000000000000087

No abstract available

Publication types

Letter
Comment

MeSH terms

Alcohol Drinking / adverse effects*
Anti-Retroviral Agents / therapeutic use*
Female
HIV Infections / epidemiology*
Humans
Male

Substances

Anti-Retroviral Agents